"Sorafenib" の関連情報検索結果
Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in ...

Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in Unresectable HCC Pharmacy Times
Targeting MCM10 disrupts cancer stemness and counteracts sorafenib resistance in hepatocellular c...

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable...

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of fer...

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis Molecular Cancer
Targeted delivery of sorafenib via biotin decorated polyaminoaspartamide-based nanoparticles for ...

Targeted delivery of sorafenib via biotin decorated polyaminoaspartamide-based nanoparticles for the hepatocarcinoma treatment ScienceDirect.com
Anlotinib/Penpulimab Enhances Survival vs Sorafenib in Unresectable HCC - CancerNetwork

Anlotinib/Penpulimab Enhances Survival vs Sorafenib in Unresectable HCC CancerNetwork
Tribbles Pseudokinase 3 Converts Sorafenib Therapy to Neutrophil-Mediated Lung Metastasis in Hepa...

Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcin...

Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment - Nature

Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment Nature
Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspect...

Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspects ScienceDirect.com
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular...

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma b...

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation Molecular Cancer
PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocell...

CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R...

Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellula...

Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC ScienceDirect.com
Combining Sorafenib, Se-methylselenocysteine, and α-Ketoacid for synergistic cytotoxicity in Hepa...

Combining Sorafenib, Se-methylselenocysteine, and α-Ketoacid for synergistic cytotoxicity in Hepatocellular carcinoma cell lines ScienceDirect.com
Camel milk extracellular vesicles-mediated co-delivery of siVEGF/sorafenib enhances the anti-hepa...

Sorafenib-loaded metal-organic framework nanoparticles for anti-hepatocellular carcinoma effects ...

Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular Carcinom...

Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular Carcinoma ACS Publications
Peroxynitrite is involved in the mitochondrial dysfunction induced by Sorafenib in liver cancer c...

Peroxynitrite is involved in the mitochondrial dysfunction induced by Sorafenib in liver cancer cells ScienceDirect.com
Systemic delivery of sorafenib tosylate loaded LeciPlex®: A comparative assessment of nano assemb...

Systemic delivery of sorafenib tosylate loaded LeciPlex®: A comparative assessment of nano assembly, biocompatibility, and In vivo drug disposition ScienceDirect.com
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocell...

Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network p...

Sensitizing sorafenib to hepatocellular carcinoma with dual-targeted and pH-responsive nanodrugs ...

Sensitizing sorafenib to hepatocellular carcinoma with dual-targeted and pH-responsive nanodrugs via overcoming the hypoxia tumor microenvironment ScienceDirect.com
GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular ...

GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma ScienceDirect.com
Optimizing interventional therapy: A homogeneous lipiodol formulation of Tirapazamine and Sorafen...

Optimizing interventional therapy: A homogeneous lipiodol formulation of Tirapazamine and Sorafenib responsive to post-embolization microenvironment ScienceDirect.com
NCOA5 induces sorafenib resistance in hepatocellular carcinoma by inhibiting ferroptosis | Cell D...

Adding SBRT to sorafenib improves survival in hepatocellular carcinoma patients - News-Medical

Adding SBRT to sorafenib improves survival in hepatocellular carcinoma patients News-Medical
How the chemotherapy drug sorafenib triggers muscle wasting through cell remodeling - Medical Xpress

How the chemotherapy drug sorafenib triggers muscle wasting through cell remodeling Medical Xpress
Fasting enhances the efficacy of Sorafenib in breast cancer via mitophagy mediated ROS-driven p53...

Fasting enhances the efficacy of Sorafenib in breast cancer via mitophagy mediated ROS-driven p53 pathway ScienceDirect.com
Phosphoproteomics profiling of sorafenib-resistant hepatocellular carcinoma patient-derived xenog...

Phosphoproteomics profiling of sorafenib-resistant hepatocellular carcinoma patient-derived xenografts reveals potential therapeutic strategies ScienceDirect.com
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for patients with unresectab...

TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating...

Suppression of Liver Fibrogenesis with Photothermal Sorafenib Nanovesicles via Selectively Inhibi...

Suppression of Liver Fibrogenesis with Photothermal Sorafenib Nanovesicles via Selectively Inhibiting Glycolysis and Amplification of Active HSCs ACS Publications
Sorafenib plus memory-like natural killer cell immunochemotherapy boosts treatment response in li...

Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoemboli...

Autocrine and paracrine LIF signals to collaborate sorafenib-resistance in hepatocellular carcino...

Autocrine and paracrine LIF signals to collaborate sorafenib-resistance in hepatocellular carcinoma and effects of Kanglaite Injection ScienceDirect.com
Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocel...

Preparation of Glutathione-Regulated Sorafenib Targeted Nanodrug Delivery System and Its Antihepa...

Preparation of Glutathione-Regulated Sorafenib Targeted Nanodrug Delivery System and Its Antihepatocellular Carcinoma Activity ACS Publications
Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein ...

Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis ScienceDirect.com
Intracellular Magnetic Hyperthermia Sensitizes Sorafenib to Orthotopic Hepatocellular Carcinoma V...

Intracellular Magnetic Hyperthermia Sensitizes Sorafenib to Orthotopic Hepatocellular Carcinoma Via Amplified Ferroptosis ACS Publications
Dual-Functional Micelles for Codelivery of Sorafenib and Dehydrodiisoeugenol in Treatment of Hepa...

Dual-Functional Micelles for Codelivery of Sorafenib and Dehydrodiisoeugenol in Treatment of Hepatocellular Carcinoma ACS Publications
Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism to evade its anti...

TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NA...

Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nr...

Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway ScienceDirect.com
From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis...

From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma ScienceDirect.com
Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma:...

Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update ScienceDirect.com
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for...

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma ScienceDirect.com
Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC - Molecular Cancer

Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC Molecular Cancer
Autophagy modulation attenuates sorafenib resistance in HCC induced in rats - Nature

Autophagy modulation attenuates sorafenib resistance in HCC induced in rats Nature
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therape...

Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines - Nature

Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines Nature
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cance...

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors - Nature

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors Nature
Sorafenib for Advanced and Refractory Desmoid Tumors - The New England Journal of Medicine

Sorafenib for Advanced and Refractory Desmoid Tumors The New England Journal of Medicine
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 - Nature

CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 Nature
Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepa...

Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis ScienceDirect.com
Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma - Science...

Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma ScienceDirect.com
Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ...

Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis Journal of Experimental & Clinical Cancer Research
Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical...

Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical modification of adenine-binding motif ScienceDirect.com
Development of fucoidan/polyethyleneimine based sorafenib-loaded self-assembled nanoparticles wit...

Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma i...

Mechanism of sorafenib resistance associated with ferroptosis in HCC - Frontiers

Mechanism of sorafenib resistance associated with ferroptosis in HCC Frontiers
SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glut...

New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sin...

New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica Nature
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechani...

Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma - ScienceDirect.com

Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma ScienceDirect.com
Protocol to screen for Sorafenib resistance regulators using pooled lentiviral shRNA library and ...

Protocol to screen for Sorafenib resistance regulators using pooled lentiviral shRNA library and a Sorafenib-resistant hepatocellular carcinoma cell model ScienceDirect.com
Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib r...

Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer ScienceDirect.com
Sorafenib inhibits LPS-induced inflammation by regulating Lyn-MAPK-NF-kB/AP-1 pathway and TLR4 ex...

GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition o...

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferropto...

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis EMBO Press
Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellula...

Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma ScienceDirect.com
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-cont...

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG ScienceDirect.com
Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption...

Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation ...

Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation Frontiers
3-hydroxyanthranic acid increases the sensitivity of hepatocellular carcinoma to sorafenib by dec...

Tumor microenvironment responsive nano-platform for overcoming sorafenib resistance of hepatocell...

Tumor microenvironment responsive nano-platform for overcoming sorafenib resistance of hepatocellular carcinoma ScienceDirect.com
Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations an...

Pharmacokinetic Exposures Associated With Oral Administration of Sorafenib in Dogs With Spontaneo...

New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to ...

New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers ScienceDirect.com
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in ...

Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma...

Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ...

Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis Journal of Experimental & Clinical Cancer Research
Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co...

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312...

MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo s...

MCL1 inhibition: a promising approach to augment the efficacy of sorafenib in NSCLC through ferro...

Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mi...

Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mitochondrial genes ScienceDirect.com
Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-...

S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT...

S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway ScienceDirect.com
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma | Acta Pha...

Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induce...

Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma Journal of Experimental & Clinical Cancer Research
Sorafenib inhibits ossification of the posterior longitudinal ligament by blocking LOXL2-mediated...

Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma ...

ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma - Nature

ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma Nature
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeosta...

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis...

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis ScienceDirect.com
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplan...

RETRACTED ARTICLE: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysi...
